Both in Pharmaceuticals
Rhythm Pharmaceuticals vs Oruka Therapeutics
Over the past year RYTM returned −18.6% and ORKA returned +243.9%; their daily moves had a correlation of 0.26.
RYTM −18.6% ORKA +243.9%Growth of $1, one year, split-adjusted
| Metric | RYTM | ORKA |
|---|---|---|
| Price | $92.57 | $96.87 |
| Market cap | $6.37B | $6.41B |
| Today | −0.54% | +0.23% |
| 1 month | −0.9% | +16.1% |
| 6 months | +13.2% | +54.8% |
| Year to date | −13.5% | +219.6% |
| 1 year | −18.7% | +250.9% |
| Revenue growth (YoY) | +46.9% | — |
| Gross margin | 87.5% | — |
| Net margin | −70.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 26.6× | — |
| Net cash | $224.8M | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 31.6% | 52.4% |
| Short % of float | 17.1% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).